Due to private reasons the CEO of Gentian Diagnostics ASA, Hilja Ibert, has decided to resign from her position. Hilja has played a key role in the growth and success of Gentian Diagnostics ASA since 2018, and her dedication and contributions to the company over the past years has been outstanding. However, following the resignation of Hilja Ibert the Nomination Committee recommend her as a candidate for the position of new Chairperson of the Board.

Her wealth of experience and strategic insights will continue to provide great value for Gentian Diagnostics ASA in this new capacity. The Company has initiated a search for Hilja Ibert´s replacement as CEO, in the meantime Gentian Diagnostics? CFO, Njaal Kind, will serve as the acting CEO.

All the announced changes will take effect as of April 29, 2024, subject to the approval by the General Meeting.